Science Explorer Back to mapMap
Discussion
Institution · Comprehensive Cancer Center Vienna

Most cited papers from Comprehensive Cancer Center Vienna

Comprehensive Cancer Center Vienna

What are the most cited papers from Comprehensive Cancer Center Vienna?

The most cited paper from Comprehensive Cancer Center Vienna is "ESMO consensus guidelines for the management of patients with metastatic colorectal cancer" (Eric Van Cutsem et al., 2016), with 3,512 citations. Next come "DNA methylation-based classification of central nervous system tumours" (3,228) and "Breast cancer" (3,056).

Showing 50 of 59 papers. Every paper with more than 531 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 ESMO consensus guidelines for the management of patients with metastatic colorectal cancer Eric Van Cutsem et al. · Annals of Oncology Open access 5 Jul 2016 3,512
2 DNA methylation-based classification of central nervous system tumours David Capper et al. · Nature Open access143 authors 13 Mar 2018 3,228
3 Breast cancer Nadia Harbeck, Frederique Madeleine Penault-Llorca, Javier Cortés et al. · Nature Reviews Disease Primers ReviewOpen access 23 Sep 2019 3,056
4 Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers Karoline B. Kuchenbaecker et al. · JAMA Open access 20 Jun 2017 2,963
5 Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer José Baselga et al. · New England Journal of Medicine Open access 7 Dec 2011 2,868
6 Renal cell carcinoma James J.-D. Hsieh, Mark P. Purdue, Sabina Signoretti et al. · Nature Reviews Disease Primers ReviewOpen access 9 Mar 2017 2,857
7 Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma Robert John Motzer et al. · New England Journal of Medicine Open access 16 Feb 2019 2,590
8 Breast cancer Nadia Harbeck, Michael Gnant · The Lancet 16 Nov 2016 2,347
9 Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Bernard J. Escudier, Camillo Porta, Manuela Schmidinger et al. · Annals of Oncology Open access Sep 2014 2,263
10 Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes Daniel J. Klionsky et al. · Autophagy Open access232 authors 16 Feb 2008 2,057
11 ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma Nicole Concin et al. · International Journal of Gynecological Cancer Open access 23 Dec 2020 2,012
12 Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Bernard Nordlinger, Halfdan Sørbye, Bengt L. G. Glimelius et al. · The Lancet Open access Mar 2008 1,952
13 Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Alan Stuart Coates et al. · Annals of Oncology Open access 4 May 2015 1,865
14 FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial Volker Heinemann et al. · The Lancet Oncology 31 Jul 2014 1,759
15 Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma Qiming Zhang et al. · Cell Open access Oct 2019 1,735
16 European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ) Marko M. Babjuk, Maximilian Burger, Otakar Čapoun et al. · European Urology 9 Sep 2021 1,707
17 A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women Elmar Armin Joura et al. · New England Journal of Medicine Open access 18 Feb 2015 1,448
18 European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update Morgan Rouprêt, Marko M. Babjuk, Éva Compérat et al. · European Urology 16 Jul 2015 1,346
19 Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial Bernard Nordlinger, Halfdan Sørbye, Bengt L. G. Glimelius et al. · The Lancet Oncology 10 Oct 2013 1,336
20 De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 Giuseppe Curigliano et al. · Annals of Oncology Open access 11 Jun 2017 1,263
21 Brain tumour cells interconnect to a functional and resistant network Matthias Osswald et al. · Nature Open access 4 Nov 2015 1,188
22 European Association for Neuro-Oncology (EANO) guideline on the diagnosis and treatment of adult astrocytic and oligodendroglial gliomas Michael Weller et al. · The Lancet Oncology Open access 5 May 2017 1,122
23 New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs Dominik Sturm et al. · Cell Open access110 authors Feb 2016 1,028
24 Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up Sibylle Loibl et al. · Annals of Oncology Open access 13 Dec 2023 991
25 European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update Morgan Rouprêt, Marko M. Babjuk, Maximilian Burger et al. · European Urology Open access 24 Jun 2020 951
26 The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies Richard Pötter et al. · Clinical and Translational Radiation Oncology Open access 11 Jan 2018 946
27 Initial steps of metastasis: Cell invasion and endothelial transmigration Franziska van Zijl, Georg Krupitza, Wolfgang Mikulits · Mutation Research/Reviews in Mutation Research Open access 20 May 2011 902
28 American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer Gary H. Lyman, Marc Carrier, Cihan Ay et al. · Blood Advances Open access 11 Feb 2021 888
29 EANO guidelines for the diagnosis and treatment of meningiomas Roland Goldbrunner, Giuseppe Caracciolo Minniti, Matthias Preusser et al. · The Lancet Oncology Open access Sep 2016 872
30 Consensus guidelines for the detection of immunogenic cell death Oliver Kepp et al. · OncoImmunology Open access 2 Sep 2014 842
31 Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourina Shona A. Hendry et al. · Advances in Anatomic Pathology Open access100 authors 2 Aug 2017 816
32 Correlation of circular RNA abundance with proliferation – exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis and normal human tissues Anna Bachmayr-Heyda, Agnes T. Reiner, Katharina Auer et al. · Scientific Reports Open access 27 Jan 2015 781
33 Therapeutic vaccines for cancer: an overview of clinical trials Ignacio Melero, Gustav Gaudernack, Winald R. Gerritsen et al. · Nature Reviews Clinical Oncology Review 8 Jul 2014 778
34 EANO guideline on the diagnosis and management of meningiomas Roland Goldbrunner, Pantelis C. Stavrinou, Michael D. Jenkinson et al. · Neuro-Oncology Open access 28 Jun 2021 765
35 Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research Shona A. Hendry et al. · Advances in Anatomic Pathology Open access100 authors 2 Aug 2017 739
36 Molecular targeted therapy of glioblastoma Émilie Le Rhun, Matthias Preusser, Patrick A. Roth et al. · Cancer Treatment Reviews Open access 11 Sep 2019 730
37 Venous thromboembolism in cancer patients: a population-based cohort study Frits I. Mulder, Erzsébet Horváth–Puhó, Nick van Es et al. · Blood Open access 10 Nov 2020 726
38 Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study Alina Emiliana Sturdza et al. · Radiotherapy and Oncology 30 Apr 2016 712
39 NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application Robert Trondl, Petra Heffeter, Christian R. Kowol et al. · Chemical Science Open access 4 Apr 2014 676
40 MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study Richard Pötter et al. · The Lancet Oncology Open access 29 Mar 2021 666
41 Role of epithelial to mesenchymal transition in hepatocellular carcinoma Gianluigi Giannelli, Petra Koudelková, Francesco Dituri et al. · Journal of Hepatology Open access 17 May 2016 654
42 EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours Émilie Le Rhun, Michael Weller, Dieta Brandsma et al. · Annals of Oncology Open access 5 May 2017 649
43 Buccal micronucleus cytome assay Philip Thomas, Nina Holland, Claudia Bolognesi et al. · Nature Protocols 7 May 2009 638
44 Cardiac Toxicity of Sunitinib and Sorafenib in Patients With Metastatic Renal Cell Carcinoma Manuela Schmidinger, Christoph Carl Zielinski, Ursula Maria Vogl et al. · Journal of Clinical Oncology Open access 7 Oct 2008 617
45 Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Miguel Martín et al. · The Lancet Oncology 626 authors 13 Nov 2017 594
46 Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma Anna Sophie Berghoff, Barbara Kiesel, Georg Widhalm et al. · Neuro-Oncology Open access 29 Oct 2014 593
47 Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses Haoyu Zhang et al. · Nature Genetics Open access276 authors 18 May 2020 587
48 Development and verification of the PAM50-based Prosigna breast cancer gene signature assay Brett Wallden, James Justin Storhoff, Torsten O. Nielsen et al. · BMC Medical Genomics Open access 21 Aug 2015 584
49 Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2 Martine J Piccart, Gabriel N. Hortobágyi, Mario Campone et al. · Annals of Oncology Open access 18 Sep 2014 579
50 Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial Arlene Chan et al. · The Lancet Oncology 12 Feb 2016 569

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.